| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |